Mainstream

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Post ContentadptRead More

You might also be interested in reading Binance CEO Richard Teng Outlines the Path Ahead; Puts Innovation, Users and Web3 at the Forefront.

February 12, 2025
In Mainstream